Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials

Abstract Background Tranexamic acid (TXA) has been proven to be effective in reducing blood loss and transfusion rate after total knee arthroplasty (TKA) without increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Recently, an increasing number of studies have been interes...

Full description

Bibliographic Details
Main Authors: Bobin Mi, Guohui Liu, Huijuan Lv, Yi Liu, Kun Zha, Qipeng Wu, Jing Liu
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13018-017-0559-2
_version_ 1798037978689306624
author Bobin Mi
Guohui Liu
Huijuan Lv
Yi Liu
Kun Zha
Qipeng Wu
Jing Liu
author_facet Bobin Mi
Guohui Liu
Huijuan Lv
Yi Liu
Kun Zha
Qipeng Wu
Jing Liu
author_sort Bobin Mi
collection DOAJ
description Abstract Background Tranexamic acid (TXA) has been proven to be effective in reducing blood loss and transfusion rate after total knee arthroplasty (TKA) without increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Recently, an increasing number of studies have been interested in applying combined intravenous (IV) with intraarticular (IA) tranexamic acid in total knee arthroplasty. The purpose of this meta-analysis was to compare the blood loss and complications of combined TXA with IV TXA or IA TXA on TKA. Methods Systematic search of literatures were conducted to identify related articles that were published in PubMed, MEDLINE, Embase, the Cochrane Library, SpringerLink, ClinicalTrials.gov, and Ovid from their inception to September 2016. All studies that compare blood loss and complications of combined TXA and IV TXA or IA TXA on TKA were included. Main outcomes were collected and analyzed by the Review Manager 5.3. Results Five studies were included in the present meta-analysis. There was significant difference in total blood loss and blood volume of drainage when compared combined TXA group with IV TXA group or IA TXA group (P < 0.05). There was no difference in transfusion rate and thromboembolic complications when comparing combined TXA with IV TXA or IA TXA alone (P > 0.05). Conclusions Compared with administration of IA TXA or IV TXA alone on TKA, combined use of TXA has advantages in reducing total blood loss and blood volume of drainage without increasing the incidence of thromboembolic complications. We recommend combined TXA as the preferred option for patients undergoing TKA.
first_indexed 2024-04-11T21:33:56Z
format Article
id doaj.art-7117bc21aa364828a229739d49e12d8e
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-11T21:33:56Z
publishDate 2017-04-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-7117bc21aa364828a229739d49e12d8e2022-12-22T04:01:48ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2017-04-011211910.1186/s13018-017-0559-2Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trialsBobin Mi0Guohui Liu1Huijuan Lv2Yi Liu3Kun Zha4Qipeng Wu5Jing Liu6Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Rheumatology, Tangdu Hospital, The Fourth Military Medical UniversityDepartment of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Tranexamic acid (TXA) has been proven to be effective in reducing blood loss and transfusion rate after total knee arthroplasty (TKA) without increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Recently, an increasing number of studies have been interested in applying combined intravenous (IV) with intraarticular (IA) tranexamic acid in total knee arthroplasty. The purpose of this meta-analysis was to compare the blood loss and complications of combined TXA with IV TXA or IA TXA on TKA. Methods Systematic search of literatures were conducted to identify related articles that were published in PubMed, MEDLINE, Embase, the Cochrane Library, SpringerLink, ClinicalTrials.gov, and Ovid from their inception to September 2016. All studies that compare blood loss and complications of combined TXA and IV TXA or IA TXA on TKA were included. Main outcomes were collected and analyzed by the Review Manager 5.3. Results Five studies were included in the present meta-analysis. There was significant difference in total blood loss and blood volume of drainage when compared combined TXA group with IV TXA group or IA TXA group (P < 0.05). There was no difference in transfusion rate and thromboembolic complications when comparing combined TXA with IV TXA or IA TXA alone (P > 0.05). Conclusions Compared with administration of IA TXA or IV TXA alone on TKA, combined use of TXA has advantages in reducing total blood loss and blood volume of drainage without increasing the incidence of thromboembolic complications. We recommend combined TXA as the preferred option for patients undergoing TKA.http://link.springer.com/article/10.1186/s13018-017-0559-2Tranexamic acidCombinedIntravenousIntraarticularTotal knee arthroplasty
spellingShingle Bobin Mi
Guohui Liu
Huijuan Lv
Yi Liu
Kun Zha
Qipeng Wu
Jing Liu
Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials
Journal of Orthopaedic Surgery and Research
Tranexamic acid
Combined
Intravenous
Intraarticular
Total knee arthroplasty
title Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials
title_full Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials
title_fullStr Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials
title_full_unstemmed Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials
title_short Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials
title_sort is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty a meta analysis of randomized controlled trials
topic Tranexamic acid
Combined
Intravenous
Intraarticular
Total knee arthroplasty
url http://link.springer.com/article/10.1186/s13018-017-0559-2
work_keys_str_mv AT bobinmi iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT guohuiliu iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT huijuanlv iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT yiliu iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT kunzha iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT qipengwu iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT jingliu iscombineduseofintravenousandintraarticulartranexamicacidsuperiortointravenousorintraarticulartranexamicacidaloneintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials